Carregant...
New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid Malignancies
The clearance of malignant clonal cells significantly correlates with clinical outcomes in many hematologic malignancies. Accurate and high throughput tools for minimal residual disease (MRD) detection are needed to overcome some drawbacks of standard molecular techniques; such novel tools have allo...
Guardat en:
| Publicat a: | J Clin Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6162632/ https://ncbi.nlm.nih.gov/pubmed/30231510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm7090288 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|